<HashMap><database>MetabolomicsWorkbench</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>http://www.metabolomicsworkbench.org/rest/study/study_id/ST001206/mwtab</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Metabolomics</omics_type><technology_type>Mass Spectrometry</technology_type><technology_type>ESI</technology_type><species>Mus Musculus</species><full_dataset_link>http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&amp;StudyID=ST001206</full_dataset_link><study_factor>Temperature:22C | Time of exposure:1 hour</study_factor><study_factor>Temperature:5C | Time of exposure:1 hour</study_factor><study_factor>Temperature:30C | Time of exposure:7 days</study_factor><study_factor>Temperature:5C | Time of exposure:7 days</study_factor><submitter_affiliation>Joslin Diabetes Center</submitter_affiliation><tissue>Blood</tissue><sample_protocol>UHPLC NEGATIVE ION MODE.</sample_protocol><repository>MetabolomicsWorkbench</repository><metabolite_name>13,14-dihydro PGE1</metabolite_name><metabolite_name>16-HETE</metabolite_name><metabolite_name>19/20-OH PGF2a</metabolite_name><metabolite_name>8-HEPE</metabolite_name><metabolite_name>8-iso PGF2a</metabolite_name><metabolite_name>13-oxoODE</metabolite_name><metabolite_name>15-deoxy-delta12,14-PGD2</metabolite_name><metabolite_name>16(17)-EpDPE</metabolite_name><metabolite_name>14,15-diHETrE</metabolite_name><metabolite_name>delta12-PGJ2</metabolite_name><metabolite_name>12-HEPE</metabolite_name><metabolite_name>20-HETE</metabolite_name><metabolite_name>9-HEPE</metabolite_name><metabolite_name>13-HODE</metabolite_name><metabolite_name>18-HETE</metabolite_name><metabolite_name>d4-9-HODE</metabolite_name><metabolite_name>15-HETE</metabolite_name><metabolite_name>Hepoxilin A3</metabolite_name><metabolite_name>LTE4</metabolite_name><metabolite_name>14-HDHA</metabolite_name><metabolite_name>PGF1a</metabolite_name><metabolite_name>5-HETrE</metabolite_name><metabolite_name>5,6-diHETE</metabolite_name><metabolite_name>9-HODE</metabolite_name><metabolite_name>17(18)-EpETE</metabolite_name><metabolite_name>15-keto-PGF2a</metabolite_name><metabolite_name>5-iPF2a-VI</metabolite_name><metabolite_name>8-HDHA</metabolite_name><metabolite_name>d8-5S-HETE</metabolite_name><metabolite_name>PGB2</metabolite_name><metabolite_name>9-HOTrE</metabolite_name><metabolite_name>5-HEPE</metabolite_name><metabolite_name>13,14-dihydro-15-keto PGA2</metabolite_name><metabolite_name>19(20)-EpDPE</metabolite_name><metabolite_name>8-HETrE</metabolite_name><metabolite_name>PGE1/PGD1</metabolite_name><metabolite_name>PGD3/PGE3</metabolite_name><metabolite_name>16-HDHA</metabolite_name><metabolite_name>19/20-OH PGE2</metabolite_name><metabolite_name>PGF2a</metabolite_name><metabolite_name>20-HDHA</metabolite_name><metabolite_name>PGK2</metabolite_name><metabolite_name>d4-LTB4</metabolite_name><metabolite_name>14,15-diHETE</metabolite_name><metabolite_name>PGA1</metabolite_name><metabolite_name>12,13-diHOME</metabolite_name><metabolite_name>13-HOTrE/13-HOTrE(r)</metabolite_name><metabolite_name>2,3-dinor TxB2</metabolite_name><metabolite_name>d4-PGE2</metabolite_name><metabolite_name>Tetranor-12-HETE</metabolite_name><metabolite_name>9-oxoODE</metabolite_name><metabolite_name>12-oxoLTB4</metabolite_name><metabolite_name>13-HDHA</metabolite_name><metabolite_name>11-HEPE</metabolite_name><metabolite_name>10-HDHA</metabolite_name><metabolite_name>8,9-diHETrE</metabolite_name><metabolite_name>tetranor-PGFM</metabolite_name><metabolite_name>Bicyclo PGE2</metabolite_name><metabolite_name>9,10-diHOME</metabolite_name><metabolite_name>13,14-dihydro-15-keto PGF2a</metabolite_name><metabolite_name>PGD2</metabolite_name><metabolite_name>Maresin1</metabolite_name><metabolite_name>8-HETE</metabolite_name><metabolite_name>11(12)-EET</metabolite_name><metabolite_name>LTB4</metabolite_name><metabolite_name>14(15)-EET</metabolite_name><metabolite_name>LXB4</metabolite_name><metabolite_name>PGA2/PGJ2</metabolite_name><metabolite_name>9-HETE</metabolite_name><metabolite_name>18-HEPE</metabolite_name><metabolite_name>12-HETE</metabolite_name><metabolite_name>15-HEPE</metabolite_name><metabolite_name>5,6-diHETrE</metabolite_name><metabolite_name>2,3-dinor-11beta-PGF2a</metabolite_name><metabolite_name>15-oxoETE</metabolite_name><metabolite_name>8(9)-EET</metabolite_name><metabolite_name>11-beta-PGF2a/PGF2b</metabolite_name><metabolite_name>6-keto-PGF1a</metabolite_name><metabolite_name>6,15-diketo-13,14-dihydro PGF1a</metabolite_name><metabolite_name>17,18-diHETE</metabolite_name><metabolite_name>4-HDHA</metabolite_name><metabolite_name>17-HDHA</metabolite_name><metabolite_name>LXA4</metabolite_name><metabolite_name>PD1</metabolite_name><metabolite_name>7-HDHA</metabolite_name><metabolite_name>15-deoxy-delta12,14-PGJ2</metabolite_name><metabolite_name>13,14-dihydro-15-keto PGE2</metabolite_name><metabolite_name>15-HETrE</metabolite_name><metabolite_name>11-HDHA</metabolite_name><metabolite_name>5-HETE</metabolite_name><metabolite_name>11-dehydro TxB2</metabolite_name><metabolite_name>9(10)-EpOME</metabolite_name><metabolite_name>20-carboxy LTB4</metabolite_name><metabolite_name>LTD4</metabolite_name><metabolite_name>15-keto-PGE2</metabolite_name><metabolite_name>11,12-diHETrE</metabolite_name><metabolite_name>13,14-dihydro-15-keto PGD2</metabolite_name><metabolite_name>PGE2/PGD2</metabolite_name><metabolite_name>5-oxoETE</metabolite_name><metabolite_name>12(13)-EpOME</metabolite_name><metabolite_name>6-keto PGE1</metabolite_name><metabolite_name>14(15)-EpETE</metabolite_name><metabolite_name>11-HETE</metabolite_name><metabolite_name>TxB3</metabolite_name><metabolite_name>17-HETE</metabolite_name><metabolite_name>TxB2</metabolite_name><metabolite_name>5,15-diHETE</metabolite_name><metabolite_name>19,20-diHDPA</metabolite_name><metabolite_name>RvD2</metabolite_name><metabolite_name>RvD1</metabolite_name><metabolite_name>12-oxoETE</metabolite_name><metabolite_name>5(6)-EET</metabolite_name><metabolite_name>LTC4</metabolite_name><data_protocol></data_protocol><name_synonyms>3.4.22.-, T22F8.160, and rna binding 2, Laboratory, DISEASE (COPD), Chronic Airflow Obstructions, Blood, Mus domesticus, CAO - Chronic airflow obstruction, mini-ICE, chronic obstructive pulmonary disease (COPD), CASP-14, CHRONIC OBSTRUCTIVE PULM DIS, circadian rhythm, Chronic obstructive pulmonary disease NOS, Serum, House Mouse, and RNA binding 1, Chronic obstructive pulmonary disease finding, Cold, PULMONARY DISEASE (COPD), Pulmonary Disease, T22F8_160, House, ATGPR7, chronic obstructive airways disease NOS (disorder), Chronic irreversible airway obstruction, Mus musculus domesticus, GRP8, GRP7, Chronic Obstructive Pulmonary Disease (COPD), Mice, Cold Temperatures, COLD (chronic obstructive lung disease), NEC in ICD9CM_2006, Swiss, CAFL - Chronic airflow limitation, Swiss Mice, Chronic Obstructive, Chronic airflow limitation, ATGRP7, disease (COPD), ATGRP8, GLYCINE RICH PROTEIN 7, NEC, Chronic, glycine-rich RNA-binding protein 8, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COPD, CHRONIC, COAD - Chronic obstructive airways disease, chronic obstructive lung disease [Ambiguous], obstructive lung disease, chronic obstructive airways disease NOS, not elsewhere classified, COAD, CASP14, mouse, Blood Serum, COLD - Chronic obstructive lung disease, chronic, PULM DIS CHRONIC OBSTRUCTIVE, Airflow Obstructions, Chronic obstructive pulmonary disease finding (finding), CHRONIC OBSTRUCTIVE AIRWAY DIS, pulmonary disease (COPD), Temperatures, Mus, CHRONIC OBSTRUCTIVE, Mini-ICE, chronic obstructive pulmonary disease and allied conditions, Chronic airway disease, NOS, GLYCINE-RICH RNA-BINDING PROTEIN 7, (COPD), chronic airway obstruction, Airflow Obstruction, chronic obstructive, CAL - Chronic airflow limitation, Mus musculus., COPD NOS, CHRONIC OBSTRUCTIVE LUNG DIS, chronic obstructive airway disease, GLYCINE-RICH PROTEIN 8, Chronic Obstructive Airways Disease, Temperature, Chronic airway obstruction, Mus musculus, Chronic obstructive lung disease, Caspase-14 subunit p10, cold, mice, Dops, GR-RBP7, Swiss Mouse, GR-RBP8, House Mice, Caspase-14 subunit p19, MICE, Laboratory Mice, domesticus, Chronic Airflow Obstruction, F2G1.4, OBSTRUCTIVE PULMONARY DISEASE (COPD), COPD - Chronic obstructive pulmonary disease, chronic obstructive lung disease (disorder), chronic obstructive airways disease, cold (chronic obstructive lung disease), Mouse, Chronic Obstructive Lung Disease, obstructive pulmonary disease (COPD), COLD, chronic obstructive lung disease, Laboratory Mouse, Serums, chronic obstructive pulmonary disease</name_synonyms><sample_synonyms>iones., Ionen, ion, Ion, ions</sample_synonyms></additional><is_claimable>false</is_claimable><name>Effects of cold exposure on serum lipidomic in mice</name><description/><dates><publication></publication></dates><accession>ST001206</accession><cross_references><TAXONOMY>10090</TAXONOMY></cross_references></HashMap>